Table 2 Hypercoagulable states and additional risk factors
Flap# | Patient# | Type | Location | Anamnesis | Risk factors | Hypercoagulability |
|---|---|---|---|---|---|---|
1A | 1.1 | DIEP right | Trunk | PAE | CRT | hFVL |
2A | 1.2 | DIEP left | Trunk | PAE | CRT | hFVL |
3A | 2.1 | DIEP | Trunk | DVT | Hormone therapy | hFVL, hPT, F VIII ↑ |
4A | 3.1 | LD/PSC | UE | DVT | – | hFVL, hPT |
5A | 4.1 | VRAM | LE | DVT | Smoking | hFVL, hPT, F VIII ↑, Protein C/S ↓ |
6A | 5.1 | DIEP | Trunk | DVT | CRT | hFVL |
7A | 6.1 | ALT | LE | PAE | – | hFVL, F VIII ↓, Protein S ↓ |
8A | 7.1 | Gracilis | LE | PAE | Smoking | hFVL, hPT, F VIII ↑, Lupusinhibitor |
9A | 7.2 | LD | LE | PAE | Smoking | hFVL, hPT, F VIII ↑, Lupusinhibitor |
10A | 7.3 | VRAM | LE | PAE | Smoking | hFVL, hPT, F VIII ↑, Lupusinhibitor |
11A | 8.1 | DIEP | Trunk | Miscarriage | CRT | hFVL, Protein C ↓ |
12A | 9.3 | LD | LE | – | Smoking | hFVL, hPT, F VIII ↑, F IX ↑, F XI ↑ |
13A | 14.2 | LD | LE | – | – | hFVL, hPT, F VIII ↑, |
14A | 15.2 | LD | LE | – | - | hFVL, hPT, F VIII ↑, |
1B | 9.1 | LD | LE | – | Smoking | hFVL, hPT, F VIII ↑, F IX ↑, F XI ↑ |
2B | 9.2 | Gracilis | LE | – | Smoking | hFVL, hPT, F VIII ↑, F IX ↑, F XI ↑ |
3B | 10.1 | LD | LE | – | – | hFVL, hPT |
4B | 11.1 | ALT | LE | – | Smoking | hFVL, hPT |
5B | 12.1 | PSC | LE | – | Smoking | hFVL, hPT |
6B | 13.1 | DIEP right | Trunk | – | CRT/Smoking | hFVL, F VIII ↓, Protein S ↓ |
7B | 13.2 | DIEP left | Trunk | – | CRT/Smoking | hFVL, F VIII ↓, Protein S ↓ |
8B | 14.1 | ALT | LE | – | – | hFVL, hPT, F VIII ↑, |
9B | 15.1 | LD | LE | – | Smoking | hFVL, hPT, F VIII ↑, |